< Back to companies

Voiceitt’s speech recognition technology, unlike standard speech recognition systems developed and distributed by the world’s major technology industry players, is designed to recognize non-standard speech patterns of people with mild to very severe speech disabilities. Supported by a combination of over $11,500,000 in government grants, corporate cash prizes, and traditional investment, the Israel-based startup developed and validated its first commercial product, a mobile application that translates unintelligible speech in real time, enabling people with severe speech impairments to communicate by voice. Tested in 2018 in four languages, five countries and over 200 users via its institutional partners, the Voiceitt app enabled by the company's proprietary speech technology enables spontaneous verbal interaction previously inaccessible to many of these individuals, who instead relied on bulky and expensive assistive communication devices - and in some cases, chose not to communicate at all. The company's goal is to validate and productize its AI-driven tech in two use cases: a mobile application enabling human to human spontaneous communication; and secondly, integration of the technology in a smart home context, enabling accessibility of voice-driven technologies to people with motor, cognitive and speech-related challenges, thus enabling independence, autonomy, inclusion, and quality of life for these individuals. Microsoft’s M12 and the Amazon Alexa Fund recently announced equity investment in Voiceitt. Voiceitt's mission is to make speech recognition technologies and products truly accessible to everyone, regardless of physical limitations or motor disabilities.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
www.voiceitt.com/

Categories

RehabilitationDigital Health ServicesAI / MLAccess to Care
Only accessible to MedStartr community members. Join now

What do you think of Voiceitt?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now